Follow us on:

Linkedin Facebook

FTSE 100

FTSE 100 Market news covers the latest developments for the FTSE 100 Index, which tracks the 100 most highly capitalised blue‑chip companies listed on the London Stock Exchange.

This category includes updates on company admissions and delistings, quarterly and annual results, mergers and acquisitions, board appointments and departures, regulatory news and policy changes.

SSE Plc

SSEN Transmission secures £1bn green loan for Scottish grid upgrades

SSEN Transmission has secured a £1 billion, 12-year bank facility backed by an £800 million guarantee from the UK Government’s National Wealth Fund to support four major grid upgrade projects in the north of Scotland...
Games Workshop Group

Games Workshop appoints Nilufer Kheraj OBE as Non-Executive Director

Games Workshop has appointed Nilufer Kheraj OBE to its Board as a Non-Executive Director with effect from 1 January 2026...
GSK

GSK secures FDA approval for Exdensur in severe eosinophilic asthma

GSK plc has received US FDA approval for Exdensur (depemokimab-ulaa) as an add-on maintenance treatment for severe asthma with an eosinophilic phenotype in patients aged 12 and over...
Diploma

Diploma appoints Wilson Ng as Group Chief Financial Officer

Diploma PLC has appointed Wilson Ng as Group Chief Financial Officer with immediate effect, following a formal internal and external selection process...
Bunzl plc

Bunzl Plc reiterates 2025 guidance ahead of year end update

Bunzl plc has reaffirmed its 2025 adjusted operating profit guidance ahead of entering its closed period, with group revenue expected to grow by 2% to 3% at constant exchange rates...
Centrica Plc

Centrica Plc agrees sale of Spirit Energy assets to Serica

Centrica has announced the sale of Spirit Energy’s remaining interests in the Cygnus gas field and other producing assets in the Southern North Sea to Serica Energy...
AstraZeneca

AstraZeneca’s Enhertu plus pertuzumab approved in US for 1st-line HER2-positive breast cancer

AstraZeneca and Daiichi Sankyo have received US FDA approval for Enhertu in combination with pertuzumab as a 1st-line treatment for adults with unresectable or metastatic HER2-positive breast cancer...
GSK plc

GSK Plc secures UK approval for Exdensur in asthma and nasal polyps

GSK has announced that Exdensur (depemokimab) has received marketing authorisation from the UK MHRA for use in certain asthma and chronic rhinosinusitis with nasal polyps patients...
Anglo American

Anglo American and Teck secure Canadian approval for merger

Anglo American and Teck Resources have received approval from the Government of Canada under the Investment Canada Act for their proposed merger of equals...
Hikma Pharmaceuticals plc

Hikma Pharmaceuticals CEO Riad Mishlawi steps down, Executive Chairman assumes role

Hikma Pharmaceuticals has announced that Riad Mishlawi has stepped down as Chief Executive Officer and as a board member by mutual agreement...
GSK plc

GSK RSV vaccine recommended for wider adult use, CHMP backs expansion

GSK has announced that the EMA’s CHMP has recommended broadening the indication of its adjuvanted RSV vaccine to adults aged 18 and over, with a final decision expected in February 2026...
Entain plc

Entain appoints Michael Snape as incoming CFO, Rob Wood announces 2026 departure

Entain has confirmed that long-serving CFO and Deputy CEO Rob Wood will step down in 2026, with Michael Snape set to join as CFO Designate in February before taking the role in March...
FirstGroup

FirstGroup selected as preferred operator for London Overground contract

FirstGroup has been named the preferred operator for the London Overground rail network under a new contract awarded by Transport for London...
Berkeley Group

Berkeley Group posts £254 million profit and maintains strong cash position in interim results

Berkeley Group has reported pre-tax profit of £254 million for the six months to 31 October 2025 and net cash of £342 million...
GSK

GSK receives US FDA Orphan Drug Designation for SCLC treatment risvutatug rezetecan

GSK has announced that its B7-H3-targeted antibody-drug conjugate, risvutatug rezetecan, has been granted Orphan Drug Designation by the US FDA for small-cell lung cancer...
Anglo American

Anglo American shareholders approve merger with Teck to form Anglo Teck

Anglo American has confirmed that shareholders voted in favour of the resolutions required to implement its merger of equals with Teck Resources Limited...
Ashtead Group

Ashtead Group delivers steady H1 results and confirms new $1.5bn buy back

Ashtead Group has posted first half results broadly in line with expectations, with rental revenue up 2 percent and free cash flow rising to $1.1 billion...
British American Tobacco

British American Tobacco reaffirms 2026 guidance and announces £1.3bn buy back

Pershing Square

Pershing Square schedules 2026 investor presentation

Pershing Square Holdings has confirmed that its annual investor presentation will take place on 11 February 2026 at 15:00 GMT, with attendance limited to current shareholders and bondholders...
Smith & Nephew plc

Smith & Nephew outlines RISE strategy with upgraded guidance and new 2028 financial targets

Smith & Nephew has introduced its RISE strategy at its Capital Markets Day, setting out 2028 targets for stronger revenue growth, higher profit and increased free cash flow...

News and Interview Alerts

Subscribe Free

Company Presentations

Q&As

Hardman & Co

Green News

View all Sustainable sectors, Plcs and news >>  

Search

Search

Latest Interviews

BrokerTalk

Funds

View all Funds, Market Insights and news >> 

FTSE 100 News

UK Broker Ratings

February 29, 2024

SSE Plc

SSEN Transmission secures £1bn green loan for Scottish grid upgrades

SSEN Transmission has secured a £1 billion, 12-year bank facility backed by an £800 million guarantee from the UK Government’s National Wealth Fund to support four major grid upgrade projects in the north of Scotland...
Games Workshop Group

Games Workshop appoints Nilufer Kheraj OBE as Non-Executive Director

Games Workshop has appointed Nilufer Kheraj OBE to its Board as a Non-Executive Director with effect from 1 January 2026...
GSK

GSK secures FDA approval for Exdensur in severe eosinophilic asthma

GSK plc has received US FDA approval for Exdensur (depemokimab-ulaa) as an add-on maintenance treatment for severe asthma with an eosinophilic phenotype in patients aged 12 and over...
Diploma

Diploma appoints Wilson Ng as Group Chief Financial Officer

Diploma PLC has appointed Wilson Ng as Group Chief Financial Officer with immediate effect, following a formal internal and external selection process...
Bunzl plc

Bunzl Plc reiterates 2025 guidance ahead of year end update

Bunzl plc has reaffirmed its 2025 adjusted operating profit guidance ahead of entering its closed period, with group revenue expected to grow by 2% to 3% at constant exchange rates...
Centrica Plc

Centrica Plc agrees sale of Spirit Energy assets to Serica

Centrica has announced the sale of Spirit Energy’s remaining interests in the Cygnus gas field and other producing assets in the Southern North Sea to Serica Energy...
AstraZeneca

AstraZeneca’s Enhertu plus pertuzumab approved in US for 1st-line HER2-positive breast cancer

AstraZeneca and Daiichi Sankyo have received US FDA approval for Enhertu in combination with pertuzumab as a 1st-line treatment for adults with unresectable or metastatic HER2-positive breast cancer...
GSK plc

GSK Plc secures UK approval for Exdensur in asthma and nasal polyps

GSK has announced that Exdensur (depemokimab) has received marketing authorisation from the UK MHRA for use in certain asthma and chronic rhinosinusitis with nasal polyps patients...
Anglo American

Anglo American and Teck secure Canadian approval for merger

Anglo American and Teck Resources have received approval from the Government of Canada under the Investment Canada Act for their proposed merger of equals...
Hikma Pharmaceuticals plc

Hikma Pharmaceuticals CEO Riad Mishlawi steps down, Executive Chairman assumes role

Hikma Pharmaceuticals has announced that Riad Mishlawi has stepped down as Chief Executive Officer and as a board member by mutual agreement...
GSK plc

GSK RSV vaccine recommended for wider adult use, CHMP backs expansion

GSK has announced that the EMA’s CHMP has recommended broadening the indication of its adjuvanted RSV vaccine to adults aged 18 and over, with a final decision expected in February 2026...
Entain plc

Entain appoints Michael Snape as incoming CFO, Rob Wood announces 2026 departure

Entain has confirmed that long-serving CFO and Deputy CEO Rob Wood will step down in 2026, with Michael Snape set to join as CFO Designate in February before taking the role in March...
FirstGroup

FirstGroup selected as preferred operator for London Overground contract

FirstGroup has been named the preferred operator for the London Overground rail network under a new contract awarded by Transport for London...
Berkeley Group

Berkeley Group posts £254 million profit and maintains strong cash position in interim results

Berkeley Group has reported pre-tax profit of £254 million for the six months to 31 October 2025 and net cash of £342 million...
GSK

GSK receives US FDA Orphan Drug Designation for SCLC treatment risvutatug rezetecan

GSK has announced that its B7-H3-targeted antibody-drug conjugate, risvutatug rezetecan, has been granted Orphan Drug Designation by the US FDA for small-cell lung cancer...
Anglo American

Anglo American shareholders approve merger with Teck to form Anglo Teck

Anglo American has confirmed that shareholders voted in favour of the resolutions required to implement its merger of equals with Teck Resources Limited...
Ashtead Group

Ashtead Group delivers steady H1 results and confirms new $1.5bn buy back

Ashtead Group has posted first half results broadly in line with expectations, with rental revenue up 2 percent and free cash flow rising to $1.1 billion...
British American Tobacco

British American Tobacco reaffirms 2026 guidance and announces £1.3bn buy back

Pershing Square

Pershing Square schedules 2026 investor presentation

Pershing Square Holdings has confirmed that its annual investor presentation will take place on 11 February 2026 at 15:00 GMT, with attendance limited to current shareholders and bondholders...
Smith & Nephew plc

Smith & Nephew outlines RISE strategy with upgraded guidance and new 2028 financial targets

Smith & Nephew has introduced its RISE strategy at its Capital Markets Day, setting out 2028 targets for stronger revenue growth, higher profit and increased free cash flow...
Load More

News and Interview Alerts

Subscribe Free

Company Presentations

Q&As

Hardman & Co

Green News

View all Sustainable sectors, Plcs and news >>  

Search

Search

Latest interviews

Broker Talk

Funds

View all Funds, Market Insights and news >> 

FTSE 100 News

UK Broker Ratings

FTSE 100

Latest Interviews

FTSE 100 News

FTSE 250 News

News and Interview Alerts

Subscribe Free

Company Presentations

Q&As

Hardman & Co

BrokerTalk

FTSE 100

Funds

View all Funds, Market Insights and news >> 

Green News

View all Sustainable sectors, Plcs and news >>  

UK Broker Ratings

Follow us on Social Media:

Home X-twitter Linkedin Facebook Spotify Apple